Raúl A Brizuela Quintanilla1*, Julián F Ruiz Torres2, Juan Y Ramos Contreras3, Norberto Alfonso Contino3 and Jorge García-Menocal Hernández3
1Second Degree Specialist in Gastroenterology, Full Professor, Assistant Researcher, Endoscopy and Gastroenterology Service of the National Center for Minimally Access Surgery, Cuba
2Second Degree Specialist in Gastroenterology, Full Professor, Endoscopy and Gastroenterology Service of the National Center for Minimally Access Surgery, Cuba
3Second Degree Specialist in Gastroenterology, Assistant Professor, Endoscopy and Gastroenterology Service of the National Center for Minimally Access Surgery, Cuba
*Corresponding Author: Raúl A Brizuela Quintanilla, Second Degree Specialist in Gastroenterology, Full Professor, Assistant Researcher, Endoscopy and Gastroenterology Service of the National Center for Minimally Access Surgery, Cuba.
Received: August 21, 2020; Published: November 25, 2020
Introduction: The Endoscopic retrograde cholangiopancreatography (ERCP) is the main therapeutic procedure at the present time like complement of the minimally invasive surgery of the biliary tracts and of the pancreas, non-exempt of complications.
Aims: Show the level of competence and performance achieved in the treatment of 14,213 biliopancreatic diseases by ERCP during 25 years at the CNCMA.
Methods: Retrospective and descriptive study of 14,462 ERCP records taken from the database of the CNCMA, which were carried out from January 4, 1995 to February 5, 2020.
Results: Of 14,462 ERCP records, 14,213 they remained for analysis; 5,148 (38%) male and 8,224 (62%) female, ages 18 to 93 years; 4,548 (34%) diagnostic and therapeutic ERCPs were performed, 8,824 (66%). The primary indication was the study of jaundice in 8,690 (65%) and the main diagnosis was choledocholithiasis (5,799 patients [43%]), followed by malignant bile duct strictures (3,685 patients, [27%]). The most widely used intervention was endoscopic sphincterotomy (6,236) to remove stones (3,267), and the placement of prostheses in the bile duct was frequently followed (3,138). Complications occurred in 449 cases, 348 (4%) during 8824 therapeutic procedures and 101 (2.2%) in diagnoses. There was a mortality of 0.19% (28 patients), 24 (0.3%) in therapeutic procedures and four (0.08%) in diagnoses.
Conclusions: Our results demonstrate the high level of competence and performance achieved and the high diagnostic value and therapeutic success of ERCP, with minimal complications.
Keywords: Endoscopic Retrograde Cholangiopancreatography; Sphincterotomy; Choledocholithiasis
Citation: Raúl A Brizuela Quintanilla., et al. “Treatment of Biliopancreatic Diseases by Endoscopic Retrograde Cholangiopancreatography. Retrospective Analysis of Twenty-five Years in a Tertiary Reference Center". Acta Scientific Gastrointestinal Disorders 3.12 (2020): 11-16.
Copyright: © 2020 Raúl A Brizuela Quintanilla., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.